Chevli Parag Anilkumar, Islam Tareq, Pokharel Yashashwi, Rodriguez Fatima, Virani Salim S, Blaha Michael J, Bertoni Alain G, Budoff Matthew, Otvos James D, Shapiro Michael D
Section on Hospital Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC (Dr Chevli).
Section on Hospital Medicine, Department of Internal Medicine, Geisinger Medical Center, Danville, PA (Dr Islam).
J Clin Lipidol. 2022 Nov-Dec;16(6):870-877. doi: 10.1016/j.jacl.2022.09.005. Epub 2022 Sep 19.
Elevated remnant-lipoprotein (RLP)-cholesterol (RLP-C) and high-sensitivity C-reactive protein (hsCRP) are each individually associated with atherosclerotic cardiovascular disease (ASCVD).
To evaluate the interplay of nuclear magnetic resonance (NMR)-derived RLP-C and hsCRP and their association with ASCVD in the Multi-Ethnic Study of Atherosclerosis (MESA).
Lipoprotein particles were measured using NMR spectroscopic analysis at baseline. RLP-C includes very-low-density lipoprotein cholesterol and intermediate-density lipoprotein cholesterol. Four groups were created as follows: Group 1: RLP-C ≤ median (≤29.14 mg/dL) and hsCRP < 2 mg/L; Group 2: RLP-C ≤ median and hsCRP≥ 2 mg/L; Group 3: RLP-C > median and hsCRP level < 2 mg/L; and Group 4: RLP-C > median and hsCRP level ≥ 2 mg/L. Kaplan-Meier survival curves and multivariable-adjusted Cox proportional hazard models were used to examine the relationship between RLP-C and hsCRP with incident ASCVD.
A total of 6,720 MESA participants (mean age 62.2 y, 53% female) with a median follow-up of 15.6 years were included. In the fully adjusted model, compared to those in the reference group (Group 1), participants in Group 2, Group 3, and Group 4 demonstrated a 20% (95% CI, -2%-48%), 18% (-4%-44%), and 43% (18%-76%) increased risk of incident ASCVD events, respectively (p < 0.01). An additive and multiplicative interaction between RLP-C and hsCRP was not statistically significant.
NMR-derived RLP-C and hsCRP showed a similar independent association with incident ASCVD. Notably, the combination of increased RLP-C and hsCRP was associated with an increased risk of future ASCVD events.
残余脂蛋白(RLP)-胆固醇(RLP-C)升高和高敏C反应蛋白(hsCRP)升高均分别与动脉粥样硬化性心血管疾病(ASCVD)相关。
在动脉粥样硬化多民族研究(MESA)中评估核磁共振(NMR)衍生的RLP-C和hsCRP之间的相互作用及其与ASCVD的关联。
在基线时使用NMR光谱分析测量脂蛋白颗粒。RLP-C包括极低密度脂蛋白胆固醇和中间密度脂蛋白胆固醇。创建四组如下:第1组:RLP-C≤中位数(≤29.14mg/dL)且hsCRP<2mg/L;第2组:RLP-C≤中位数且hsCRP≥2mg/L;第3组:RLP-C>中位数且hsCRP水平<2mg/L;第4组:RLP-C>中位数且hsCRP水平≥2mg/L。使用Kaplan-Meier生存曲线和多变量调整的Cox比例风险模型来检查RLP-C和hsCRP与新发ASCVD之间的关系。
共纳入6720名MESA参与者(平均年龄62.2岁,53%为女性),中位随访时间为15.6年。在完全调整模型中,与参考组(第1组)相比,第2组、第3组和第4组的参与者发生ASCVD事件的风险分别增加20%(95%CI,-2%-48%)、18%(-4%-44%)和43%(18%-76%)(p<0.01)。RLP-C和hsCRP之间的相加和相乘相互作用无统计学意义。
NMR衍生的RLP-C和hsCRP与新发ASCVD显示出相似的独立关联。值得注意的是,RLP-C和hsCRP升高的组合与未来发生ASCVD事件的风险增加相关。